SEC annual filings · research and development expense
Which companies spend the most on research and development?
In 2025, 1,187 of the 3,069 companies in our set filed a research and development expense that passes our checks; Alphabet Inc. filed the largest, $61.1 billion. The latest fiscal year end among the ranked companies is .
Right now
Alphabet Inc. reported the largest research and development expense of the ranked companies for 2025, $61.1 billion.
1,187 of the 3,069 companies in our set have a figure for 2025 that passes our checks; the 25 with the largest are listed below.
As filed
Research and development expense is the money a company reports it spent in a fiscal year on work to create or improve its products, as it files it with the SEC. Facts as filed with the SEC, and our arithmetic on them. Not investment advice.
Our set is the companies that have had revenue of 100 million dollars or more in the SEC data we read; smaller companies are not in it. A company that files no such figure, or one that fails our checks, is not ranked. We read the three names the SEC data gives the expense: the plain one, the one that leaves out acquired in-process research and development (many drug companies file that one, so their figure is without it) and the software one; one figure is taken for each company and year, never the sum of two. Some companies count research inside other costs or file it under a label of their own, as Amazon does with technology and infrastructure, and are not ranked. A company missing here can still spend on research.
0 companies that filed a figure for 2024 are still to file 2025, so the order is final. A year is named for the year the SEC files it under, so fiscal years that end in different months share a name: the fiscal years of the companies ranked for 2025 end between 30 June 2025 and 28 June 2026. The fiscal year end of each row is shown.
Understanding the ranking
Where it stands today
Alphabet Inc. reported $61.1 billion, the largest figure of the ranked companies in 2025.
What is research and development expense?
The ranking lists companies by the research and development expense they filed for their fiscal year in 2025, the largest first.
Read more
Research and development expense is the money a company reports it spent in a fiscal year on work to create or improve its products, as it files it with the SEC.
A parent and an affiliate that file the same figure are both ranked, so one figure can appear twice. Each company's own figure for every year is on its page.
The numbers behind the chart
Which companies spent the most on research and development in 2025?25 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $61.1B | |
| Meta Platforms, Inc. | 2 | META | $57.4B | |
| Apple Inc. | 3 | AAPL | $34.5B | |
| Microsoft Corp | 4 | MSFT | $32.5B | |
| NVIDIA Corp | 5 | NVDA | $18.5B | |
| Merck & Co., Inc. | 6 | MRK | $15.8B | |
| Johnson & Johnson | 7 | JNJ | $14.7B | |
| Intel Corp | 8 | INTC | $13.8B | |
| Eli Lilly & Co | 9 | LLY | $13.3B | |
| Broadcom Inc. | 10 | AVGO | $11.0B | |
| Pfizer Inc | 11 | PFE | $10.4B | |
| Oracle Corp | 12 | ORCL | $10.3B | |
| Bristol-Myers Squibb Co | 13 | BMY | $9.95B | |
| Alibaba Group Holding Ltd | 14 | BABA | $9.64B | |
| Ford Motor Co | 15 | F | $9.40B | |
| Cisco Systems, Inc. | 16 | CSCO | $9.30B | |
| AbbVie Inc. | 17 | ABBV | $9.10B | |
| Qualcomm Inc | 18 | QCOM | $9.04B | |
| International Business Machines Corp | 19 | IBM | $8.32B | |
| Advanced Micro Devices Inc | 20 | AMD | $8.09B | |
| Amgen Inc | 21 | AMGN | $7.27B | |
| Tesla, Inc. | 22 | TSLA | $6.41B | |
| Salesforce, Inc. | 23 | CRM | $5.99B | |
| Regeneron Pharmaceuticals, Inc. | 24 | REGN | $5.85B | |
| Gilead Sciences, Inc. | 25 | GILD | $5.80B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2024?10 of 1,197 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $49.3B | |
| Meta Platforms, Inc. | 2 | META | $43.9B | |
| Apple Inc. | 3 | AAPL | $31.4B | |
| Microsoft Corp | 4 | MSFT | $29.5B | |
| Merck & Co., Inc. | 5 | MRK | $17.9B | |
| Johnson & Johnson | 6 | JNJ | $17.2B | |
| Intel Corp | 7 | INTC | $16.5B | |
| NVIDIA Corp | 8 | NVDA | $12.9B | |
| AbbVie Inc. | 9 | ABBV | $12.8B | |
| Bristol-Myers Squibb Co | 10 | BMY | $11.2B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2023?10 of 1,195 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $45.4B | |
| Meta Platforms, Inc. | 2 | META | $38.5B | |
| Merck & Co., Inc. | 3 | MRK | $30.5B | |
| Apple Inc. | 4 | AAPL | $29.9B | |
| Microsoft Corp | 5 | MSFT | $27.2B | |
| Intel Corp | 6 | INTC | $16.0B | |
| Johnson & Johnson | 7 | JNJ | $15.1B | |
| Pfizer Inc | 8 | PFE | $10.7B | |
| Eli Lilly & Co | 9 | LLY | $9.31B | |
| Bristol-Myers Squibb Co | 10 | BMY | $9.30B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2022?10 of 1,159 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $39.5B | |
| Meta Platforms, Inc. | 2 | META | $35.3B | |
| Apple Inc. | 3 | AAPL | $26.3B | |
| Microsoft Corp | 4 | MSFT | $24.5B | |
| Intel Corp | 5 | INTC | $17.5B | |
| Johnson & Johnson | 6 | JNJ | $14.1B | |
| Merck & Co., Inc. | 7 | MRK | $13.5B | |
| Pfizer Inc | 8 | PFE | $11.4B | |
| Bristol-Myers Squibb Co | 9 | BMY | $9.51B | |
| Oracle Corp | 10 | ORCL | $8.62B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2021?10 of 1,126 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $31.6B | |
| Meta Platforms, Inc. | 2 | META | $24.7B | |
| Apple Inc. | 3 | AAPL | $21.9B | |
| Microsoft Corp | 4 | MSFT | $20.7B | |
| Intel Corp | 5 | INTC | $15.2B | |
| Johnson & Johnson | 6 | JNJ | $14.3B | |
| Merck & Co., Inc. | 7 | MRK | $12.2B | |
| Pfizer Inc | 8 | PFE | $10.4B | |
| Bristol-Myers Squibb Co | 9 | BMY | $10.2B | |
| Alibaba Group Holding Ltd | 10 | BABA | $8.75B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2020?10 of 1,096 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $27.6B | |
| Microsoft Corp | 2 | MSFT | $19.3B | |
| Apple Inc. | 3 | AAPL | $18.8B | |
| Meta Platforms, Inc. | 4 | META | $18.4B | |
| Intel Corp | 5 | INTC | $13.6B | |
| Merck & Co., Inc. | 6 | MRK | $13.4B | |
| Johnson & Johnson | 7 | JNJ | $12.2B | |
| Bristol-Myers Squibb Co | 8 | BMY | $10.0B | |
| Alibaba Group Holding Ltd | 9 | BABA | $8.74B | |
| Pfizer Inc | 10 | PFE | $8.71B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2019?10 of 1,051 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $26.0B | |
| Microsoft Corp | 2 | MSFT | $16.9B | |
| Apple Inc. | 3 | AAPL | $16.2B | |
| Meta Platforms, Inc. | 4 | META | $13.6B | |
| Intel Corp | 5 | INTC | $13.4B | |
| Johnson & Johnson | 6 | JNJ | $11.4B | |
| Merck & Co., Inc. | 7 | MRK | $9.72B | |
| Gilead Sciences, Inc. | 8 | GILD | $9.11B | |
| Pfizer Inc | 9 | PFE | $8.38B | |
| Ford Motor Co | 10 | F | $7.40B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2018?10 of 938 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $21.4B | |
| Microsoft Corp | 2 | MSFT | $14.7B | |
| Apple Inc. | 3 | AAPL | $14.2B | |
| Intel Corp | 4 | INTC | $13.5B | |
| Johnson & Johnson | 5 | JNJ | $10.8B | |
| AbbVie Inc. | 6 | ABBV | $10.3B | |
| Meta Platforms, Inc. | 7 | META | $10.3B | |
| Merck & Co., Inc. | 8 | MRK | $9.75B | |
| Ford Motor Co | 9 | F | $8.20B | |
| Pfizer Inc | 10 | PFE | $7.76B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2017?10 of 880 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $16.6B | |
| Microsoft Corp | 2 | MSFT | $13.0B | |
| Intel Corp | 3 | INTC | $13.0B | |
| Apple Inc. | 4 | AAPL | $11.6B | |
| Johnson & Johnson | 5 | JNJ | $10.6B | |
| Merck & Co., Inc. | 6 | MRK | $10.3B | |
| Ford Motor Co | 7 | F | $8.00B | |
| Meta Platforms, Inc. | 8 | META | $7.75B | |
| Pfizer Inc | 9 | PFE | $7.68B | |
| Bristol-Myers Squibb Co | 10 | BMY | $6.47B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2016?10 of 839 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $13.9B | |
| Intel Corp | 2 | INTC | $12.7B | |
| Microsoft Corp | 3 | MSFT | $12.0B | |
| Merck & Co., Inc. | 4 | MRK | $10.3B | |
| Apple Inc. | 5 | AAPL | $10.0B | |
| Johnson & Johnson | 6 | JNJ | $9.14B | |
| Pfizer Inc | 7 | PFE | $7.89B | |
| Ford Motor Co | 8 | F | $7.30B | |
| Cisco Systems, Inc. | 9 | CSCO | $6.30B | |
| Oracle Corp | 10 | ORCL | $6.15B |
The table scrolls sideways; the first column stays in place.
Which companies spent the most on research and development in 2015?10 of 791 companies
| Company | Rank | Symbol | Fiscal year ended | Spent |
|---|---|---|---|---|
| Alphabet Inc. | 1 | GOOGL | $12.3B | |
| Intel Corp | 2 | INTC | $12.1B | |
| Microsoft Corp | 3 | MSFT | $12.0B | |
| Johnson & Johnson | 4 | JNJ | $9.05B | |
| Apple Inc. | 5 | AAPL | $8.07B | |
| Pfizer Inc | 6 | PFE | $7.69B | |
| Merck & Co., Inc. | 7 | MRK | $6.70B | |
| Ford Motor Co | 8 | F | $6.70B | |
| Cisco Systems, Inc. | 9 | CSCO | $6.21B | |
| Bristol-Myers Squibb Co | 10 | BMY | $5.92B |
The table scrolls sideways; the first column stays in place.
What does the ranking leave out, and where is it from?Limits and source
What this number cannot tell you
- Only companies with a research and development figure above zero for the year that passes our checks are ranked, the largest first; equal figures share a rank.
- Our set is the companies that have had revenue of 100 million dollars or more in the SEC data we read; smaller companies are not in it.
- A company that files no such figure, or one that fails our checks, is not ranked. We read the three names the SEC data gives the expense: the plain one, the one that leaves out acquired in-process research and development (many drug companies file that one, so their figure is without it) and the software one; one figure is taken for each company and year, never the sum of two. Some companies count research inside other costs or file it under a label of their own, as Amazon does with technology and infrastructure, and are not ranked. A company missing here can still spend on research.
- A year is named for the year the SEC files it under, so fiscal years that end in different months share a name: the fiscal years of the companies ranked for 2025 end between 30 June 2025 and 28 June 2026. The fiscal year end of each row is shown.
- A parent and an affiliate that file the same figure are both ranked, so one figure can appear twice.
- 0 companies that filed a figure for 2024 are still to file 2025, so the order is final.
- The tables of earlier years list the ten largest figures of each year since 2015. A company that has stopped filing is listed in the years it filed.
- A figure is held back when it fails one of our checks: when the SEC data flags it, when it is for another period than the year, when it is below zero, or when the newest year is far from the company's years before it.
Observed .
Page updated